3-iodobenzylguanidine has been researched along with Injuries, Radiation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchpiguel, CA; Coura-Filho, GB; Crema, KP; Oliveira, NC; Pelissoni, RA; Sapienza, MT; Willegaignon, J | 1 |
| Arai-Okuda, H; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tani, R; Yamamoto, Y | 1 |
| Clement, SC; Kraal, KC; Kremer, LC; Tytgat, GA; van den Bos, C; van Eck-Smit, BL; van Santen, HM | 1 |
| Cohn, SL; Giammarile, F; Ladenstein, R; Lewington, V; Matthay, KK; Michon, J; Pearson, AD; Shulkin, B | 1 |
| Menda, Y; O'Dorisio, MS; Pashankar, FD | 1 |
| Brophy, P; Cheng, SC; Goldsby, R; Hawkins, RA; Huberty, J; Kersun, LS; Maris, JM; Matthay, KK; Messina, J; Quach, A; Veatch, J; Yanik, G | 1 |
| de Kraker, J; de Vijlder, JJ; van Eck, BL; van Santen, HM; Vulsma, T | 1 |
| Ackery, D; Fielding, S; Flower, MA; Kemshead, J; Lashford, LS; Lewis, IJ | 1 |
| de Lange, P | 1 |
| Kelly, JU | 1 |
2 review(s) available for 3-iodobenzylguanidine and Injuries, Radiation
| Article | Year |
|---|---|
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Topics: 3-Iodobenzylguanidine; Advisory Committees; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Practice Guidelines as Topic; Radiation Injuries; Radiographic Image Enhancement; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed, Single-Photon | 2010 |
MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.
Topics: 3-Iodobenzylguanidine; Animals; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Infant, Newborn; Neuroblastoma; Octreotide; Patient Selection; Pentetic Acid; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Treatment Outcome | 2005 |
2 trial(s) available for 3-iodobenzylguanidine and Injuries, Radiation
| Article | Year |
|---|---|
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Logistic Models; Lymph Node Excision; Neoplasm Staging; Neuroblastoma; Radiation Injuries; Radiopharmaceuticals; Time Factors; Treatment Failure; Treatment Outcome; United States | 2007 |
A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: 3-Iodobenzylguanidine; Anemia; Antineoplastic Agents; Child, Preschool; Drug Evaluation; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Neutropenia; Radiation Injuries; Radionuclide Imaging; Thrombocytopenia | 1991 |
6 other study(ies) available for 3-iodobenzylguanidine and Injuries, Radiation
| Article | Year |
|---|---|
Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Brain Neoplasms; Caregivers; Child; Child, Preschool; Female; Humans; Infant; Male; Medical Staff; Metabolic Clearance Rate; Neuroblastoma; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Safety | 2018 |
Radiation-induced myocardial damage indicated by focal defect on
Topics: 3-Iodobenzylguanidine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiation Injuries; Tomography, Emission-Computed, Single-Photon | 2019 |
Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Humans; Iodine Radioisotopes; Neuroblastoma; Primary Ovarian Insufficiency; Radiation Injuries; Spinal Cord Compression; Spinal Neoplasms | 2014 |
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Potassium Iodide; Premedication; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine | 2002 |
[Pediatric oncology. I-131-MIBG and radiation health].
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Personnel, Hospital; Radiation Injuries; Radiation Monitoring; Radiation Protection; Sympatholytics | 1989 |
The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.
Topics: 3-Iodobenzylguanidine; Adult; Child; Clinical Protocols; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Patient Isolation; Potassium Iodide; Radiation Injuries; Sympatholytics; Thyroid Gland | 1989 |